Atlas Trials

Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes

Clinical trial NCT01697618 · COMPLETED

Trial details

NCT number
NCT01697618
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
1997-04-01
Primary completion
1998-11-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.